You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunoglobulin M

Showing 1 - 25 of 4,196
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Positive Rate of M Protein Based onHighly Sensitive Serum M

Recruiting
  • Multiple Myeloma
  • M Protein
    • Guangzhou, Guangdong, China
      Zhujiang Hospital of Southern Medical University
    Oct 9, 2023

    Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

    Not yet recruiting
    • Monoclonal Gammopathy of Uncertain Significance
    • Zanubrutinib Oral Product
    • Utrecht, Netherlands
      University Medical Center Utrecht
    Jul 6, 2023

    Immunoglobulin M-Anti-myelin-associated-glycoprotein(MAG)

    Recruiting
    • Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy
    • Clinical examination and patients' questionnaires regarding activity and participation (preliminary Immunogloblin M (IgM)-Rasch-built overall Disability Scale (RODS), and finalized IgM-RODS)
    • Bron, France
    • +1 more
    Mar 22, 2022

    Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin

    Recruiting
    • Myasthenia Gravis
    • subcutaneous immunoglobulin (SCIG)
    • intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
    • Toronto, Ontario, Canada
      University Health Network
    Nov 21, 2022

    Covid19 Trial in Wauwatosa (COVID-19 SARS-CoV IgG/IgM antibody rapid test)

    Recruiting
    • Covid19
    • COVID-19 SARS-CoV IgG/IgM antibody rapid test
    • Wauwatosa, Wisconsin
      Froedtert Health WAC
    Jun 21, 2021

    Schnitzler Syndrome, Urticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder) Trial in United

    Not yet recruiting
    • Schnitzler Syndrome
    • Urticarial Vasculitis With Monoclonal Immunoglobulin M Component, Schnitzler (Disorder)
    • 80 mg RPH-104
    • Placebo
    • Denver, Colorado
    • +3 more
    Dec 21, 2022

    Immunoglobulins, Plasmapheresis and Rituximab in Lung

    Recruiting
    • Lung Transplantation
    • Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies
    • blood samples
    • Hannover, Germany
      Hannover Medical School, Department of Cardiothoracic, Transplan
    Aug 30, 2021

    Myasthenia Gravis Trial in Edmonton, Vancouver (Human normal immunoglobulin G (IgG))

    Recruiting
    • Myasthenia Gravis
    • Human normal immunoglobulin G (IgG)
    • Edmonton, Alberta, Canada
    • +1 more
    May 25, 2022

    Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

    Active, not recruiting
    • Multiple Myeloma
    • AL Amyloidosis
    • Siltuximab
    • The M.D. Anderson Symptom Inventory (MDASI)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

    Active, not recruiting
    • Light Chain Deposition Disease
    • Primary Systemic Amyloidosis
    • Denver, Colorado
    • +4 more
    Jan 20, 2023

    Pregnancy Related Trial in Ukraine (Human Anti-D (rh) immunoglobulin)

    Recruiting
    • Pregnancy Related
    • Human Anti-D (rh) immunoglobulin
    • Cherkasy, Cherkasy Region, Ukraine
    • +15 more
    Jun 23, 2022

    IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)

    Active, not recruiting
    • IgA Nephropathy (IgAN)
    • +2 more
    • Vancouver, British Columbia, Canada
    • +19 more
    Jan 13, 2023

    Lupus Nephritis, Immunoglobulin A Nephropathy, IgAN Trial in United States (ALXN2050, Placebo)

    Recruiting
    • Lupus Nephritis
    • +3 more
    • Huntsville, Alabama
    • +49 more
    Jan 25, 2023

    Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,

    Completed
    • Metastatic Carcinoma in the Liver
    • +4 more
    • Durvalumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

    Recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • +3 more
    • Durvalumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 10, 2022

    Real-world CANadian CUvitru Non-Interventional Study in Subjects

    Completed
    • Primary Immunodeficiency Diseases (PID)
    • CUVITRU
    • Hamilton, Ontario, Canada
    • +2 more
    Mar 3, 2021

    Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

    Completed
    Has Results
    • Castration-Resistant Prostate Carcinoma
    • +5 more
    • Durvalumab
    • Tremelimumab
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 9, 2022

    Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

    Active, not recruiting
    • Recurrent Brain Neoplasm
    • Bevacizumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Dermatomyositis Trial in Moscow (Octanorm, Placebo)

    Terminated
    Has Results
    • Dermatomyositis
    • Moscow, Russian Federation
      I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY Rheumatology
    Apr 22, 2021

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +8 more
    • Durvalumab
    • Tremelimumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 19, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +5 more
    • Durvalumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

    Recruiting
    • Folliculotropic Mycosis Fungoides
    • +7 more
    • Durvalumab
    • +2 more
    • Duarte, California
    • +3 more
    Jan 12, 2023

    Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

    Recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2022

    Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma Trial in Houston (Durvalumab,

    Recruiting
    • Metastatic Angiosarcoma
    • +7 more
    • Durvalumab
    • Oleclumab
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2021

    Covid19 Trial in San José (Administration of Equine immunoglobulin anti SARS-CoV-2)

    Completed
    • Covid19
    • Administration of Equine immunoglobulin anti SARS-CoV-2
    • San José, Costa Rica
    • +3 more
    Mar 18, 2021